TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,060 | -18.6% | 521 | -18.0% | 0.00% | 0.0% |
| Q2 2023 | $9,906 | 0.0% | 635 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $9,906 | 0.0% | 635 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $9,906 | +23.8% | 635 | -2.3% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | -11.1% | 650 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $9,000 | -10.0% | 650 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | -9.1% | 650 | -21.4% | 0.00% | -33.3% |
| Q4 2021 | $11,000 | -31.2% | 827 | -12.7% | 0.00% | -25.0% |
| Q3 2021 | $16,000 | 0.0% | 947 | -1.1% | 0.00% | 0.0% |
| Q2 2021 | $16,000 | -15.8% | 958 | -8.5% | 0.00% | -20.0% |
| Q1 2021 | $19,000 | 0.0% | 1,047 | 0.0% | 0.01% | -16.7% |
| Q4 2020 | $19,000 | +26.7% | 1,047 | +22.6% | 0.01% | +100.0% |
| Q3 2020 | $15,000 | 0.0% | 854 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $15,000 | +7.1% | 854 | -10.4% | 0.01% | -14.3% |
| Q1 2020 | $14,000 | -39.1% | 953 | -19.7% | 0.01% | -22.2% |
| Q4 2019 | $23,000 | +21.1% | 1,187 | +5.4% | 0.01% | +50.0% |
| Q3 2019 | $19,000 | 0.0% | 1,126 | +6.4% | 0.01% | -25.0% |
| Q2 2019 | $19,000 | -24.0% | 1,058 | -12.9% | 0.01% | -20.0% |
| Q1 2019 | $25,000 | +92.3% | 1,215 | +62.7% | 0.01% | +66.7% |
| Q4 2018 | $13,000 | – | 747 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |